Introduction

This page provides a comprehensive analysis of the known insider trading history of Robert E Funck. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Robert E Funck has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ABT / Abbott Laboratories EXECUTIVE VICE PRESIDENT 211,341
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Robert E Funck. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Robert E Funck as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2024-05-14 2024-05-10 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -10,097 211,341 -4.56 104.57 -1,055,819 22,099,421
2024-05-14 2024-05-10 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 10,097 221,438 4.78 47.00 474,559 10,407,586
2024-03-04 2024-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -11,415 211,341 -5.12 120.05 -1,370,371 25,371,487
2024-02-23 2024-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 24,519 222,756 12.37
2023-09-15 2023-09-13 4 ABT ABBOTT LABORATORIES
Common shares without par value 		G - Gift 10,000 20,000 100.00
2023-09-15 2023-09-13 4 ABT ABBOTT LABORATORIES
Common shares without par value 		G - Gift 10,000 20,000 100.00
2023-09-15 2023-09-13 4 ABT ABBOTT LABORATORIES
Common shares without par value 		G - Gift -20,000 198,237 -9.16
2023-03-02 2023-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -1,264 218,237 -0.58 100.70 -127,285 21,976,466
2023-03-02 2023-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -11,500 219,501 -4.98 99.77 -1,147,355 21,899,615
2023-02-22 2023-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 24,419 231,001 11.82
2022-03-02 2022-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -10,750 206,582 -4.95 122.41 -1,315,908 25,287,703
2022-02-23 2022-02-18 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 133,670 133,670
2022-02-23 2022-02-18 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 28,682 217,332 15.20
2021-04-30 2021-04-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		G - Gift -700 188,650 -0.37
2021-03-02 2021-02-26 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -10,136 189,350 -5.08 121.58 -1,232,335 23,021,173
2021-02-23 2021-02-19 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 123,966 123,966
2021-02-23 2021-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 24,185 199,486 13.80
2021-02-04 2021-02-02 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -31,325 0 -100.00
2021-02-04 2021-02-02 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -18,241 175,301 -9.42 122.54 -2,235,252 21,481,385
2021-02-04 2021-02-02 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 31,325 193,542 19.31 39.12 1,225,434 7,571,363
2020-12-18 2020-12-15 4 ABT ABBOTT LABORATORIES
Common shares without par value 		G - Gift 10,000 10,000
2020-12-18 2020-12-15 4 ABT ABBOTT LABORATORIES
Common shares without par value 		G - Gift 10,000 10,000
2020-12-18 2020-12-15 4 ABT ABBOTT LABORATORIES
Common shares without par value 		G - Gift -20,000 162,217 -10.98
2020-10-28 2020-10-26 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -83,333 0 -100.00
2020-10-28 2020-10-26 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -83,333 182,217 -31.38 108.83 -9,068,955 19,830,293
2020-10-28 2020-10-26 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 83,333 265,550 45.73 38.40 3,199,987 10,197,120
2020-04-23 2020-04-21 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -13,000 31,325 -29.33
2020-04-23 2020-04-21 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -23,700 0 -100.00
2020-04-23 2020-04-21 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -23,855 182,217 -11.58 98.00 -2,337,790 17,857,266
2020-04-23 2020-04-21 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 13,000 206,072 6.73 39.12 508,560 8,061,537
2020-04-23 2020-04-21 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 23,700 193,072 13.99 34.94 828,078 6,745,936
2020-03-03 2020-03-02 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -1,356 169,372 -0.79 77.89 -105,619 13,192,385
2020-03-03 2020-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -6,710 170,728 -3.78 79.19 -531,365 13,519,950
2020-02-25 2020-02-21 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 154,013 154,013
2020-02-25 2020-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 25,265 177,438 16.60
2019-08-13 2019-08-09 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -40,000 23,700 -62.79
2019-08-13 2019-08-09 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -26,818 152,173 -14.98 85.56 -2,294,548 13,019,922
2019-08-13 2019-08-09 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 40,000 178,991 28.78 34.94 1,397,600 6,253,946
2019-03-04 2019-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -1,002 138,991 -0.72 78.00 -78,156 10,841,298
2019-03-04 2019-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -4,680 139,993 -3.23 77.23 -361,436 10,811,659
2019-02-26 2019-02-22 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 122,367 122,367
2019-02-26 2019-02-22 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 23,344 144,673 19.24
2018-09-07 2018-09-05 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -14,400 0 -100.00
2018-09-07 2018-09-05 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -12,300 0 -100.00
2018-09-07 2018-09-05 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -9,700 0 -100.00
2018-09-07 2018-09-05 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -23,751 121,329 -16.37 67.11 -1,593,930 8,142,389
2018-09-07 2018-09-05 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 14,400 145,080 11.02 27.03 389,284 3,922,035
2018-09-07 2018-09-05 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 12,300 130,680 10.39 22.39 275,420 2,926,173
2018-09-07 2018-09-05 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 9,700 118,380 8.93 26.19 254,023 3,100,124
2018-06-07 2018-06-05 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -12,800 0 -100.00
2018-06-07 2018-06-05 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -8,613 108,680 -7.34 63.02 -542,791 6,849,014
2018-06-07 2018-06-05 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 12,800 117,293 12.25 26.02 332,992 3,051,377
2018-03-02 2018-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -1,220 104,493 -1.15 58.99 -71,970 6,164,251
2018-03-02 2018-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -2,654 105,713 -2.45 60.55 -160,700 6,400,922
2018-02-21 2018-02-16 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 110,146 110,146
2018-02-21 2018-02-16 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 20,030 108,367 22.67
2017-03-02 2017-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -3,742 88,337 -4.06 45.46 -170,111 4,015,800
2017-02-24 2017-02-23 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -25,500 0 -100.00
2017-02-24 2017-02-23 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -25,500 92,079 -21.69 45.50 -1,160,250 4,189,594
2017-02-24 2017-02-23 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 25,500 117,579 27.69 26.70 680,781 3,139,042
2017-02-22 2017-02-17 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 48,831 48,831
2017-02-22 2017-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 7,060 92,079 8.30
2016-07-27 2016-07-25 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -26,800 0 -100.00
2016-07-27 2016-07-25 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -26,800 85,019 -23.97 43.08 -1,154,544 3,662,619
2016-07-27 2016-07-25 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 26,800 111,819 31.52 25.25 676,595 2,822,994
2016-03-02 2016-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -300 85,019 -0.35 39.30 -11,791 3,341,442
2016-03-02 2016-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -100 85,319 -0.12 39.30 -3,930 3,353,378
2016-03-02 2016-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -933 85,419 -1.08 39.30 -36,672 3,357,394
2016-03-02 2016-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -2,838 86,352 -3.18 39.52 -112,158 3,412,631
2016-02-23 2016-02-19 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 83,333 83,333
2016-02-23 2016-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 9,505 89,190 11.93
2015-07-30 2015-07-29 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -26,000 0 -100.00
2015-07-30 2015-07-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -17,763 79,685 -18.23 50.94 -904,847 4,059,154
2015-07-30 2015-07-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 26,000 97,448 36.39 21.22 551,704 2,067,788
2015-03-03 2015-02-27 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -2,922 71,448 -3.93 47.61 -139,116 3,401,639
2015-02-24 2015-02-20 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 55,097 55,097
2015-02-24 2015-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 7,819 74,370 11.75
2015-02-17 2015-02-13 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -10,542 0 -100.00
2015-02-17 2015-02-13 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -6,917 66,551 -9.41 45.22 -312,787 3,009,436
2015-02-17 2015-02-13 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 10,542 73,468 16.75 22.27 234,739 1,635,912
2014-03-04 2014-03-03 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -700 62,926 -1.10 38.97 -27,282 2,452,478
2014-03-04 2014-03-03 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -713 63,626 -1.11 38.97 -27,786 2,479,569
2014-03-04 2014-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -3,129 64,339 -4.64 39.79 -124,503 2,560,049
2014-02-25 2014-02-21 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 44,325 44,325
2014-02-25 2014-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 7,240 67,468 12.02
2014-02-04 2014-01-31 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -1,546 0 -100.00
2014-02-04 2014-01-31 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -5,715 0 -100.00
2014-02-04 2014-01-31 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -2,137 0 -100.00
2014-02-04 2014-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -1,192 60,228 -1.94 36.21 -43,162 2,180,856
2014-02-04 2014-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -5,608 61,420 -8.37 36.20 -203,010 2,223,404
2014-02-04 2014-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -2,598 67,028 -3.73 36.19 -94,022 2,425,743
2014-02-04 2014-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 1,546 69,626 2.27 35.08 54,234 2,442,480
2014-02-04 2014-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 5,715 68,080 9.16 33.88 193,624 2,306,550
2014-02-04 2014-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 2,137 62,365 3.55 31.61 67,547 1,971,239
2013-03-08 3 ABT ABBOTT LABORATORIES
Common shares without par value 		60,228
2013-03-08 3 ABT ABBOTT LABORATORIES
Common shares without par value 		15,300
2013-03-08 3 ABT ABBOTT LABORATORIES
Common shares without par value 		500
2013-03-08 3 ABT ABBOTT LABORATORIES
Common shares without par value 		500
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)